...
search icon
limn-img

Liminatus Pharma, Inc. Class A Common Stock, Common Stock

LIMN

NMQ

$5.07

-$0.49

(-8.81%)

1D

Analyst Forecast

Price Chart

Key Metrics

Market Cap info-icon
This is a company’s total value as determined by the stock market. It is calculated by multiplying the total number of a company's outstanding shares by the current market price of one share.
$135.44M
P/E Ratio info-icon
This is the ratio of a security’s current share price to its earnings per share. This ratio determines the relative value of a company’s share.
0
Volume info-icon
This is the total number of shares traded during the most recent trading day.
10.96K
Avg Volume info-icon
This is the average number of shares traded during the most recent 30 days.
0
Dividend Yield info-icon
This ratio shows how much income you earn in dividend payouts per year for every dollar invested in the stock (or the stock’s annual dividend payment expressed as a percentage of its current price).
0.00%
Beta info-icon
This measures the expected move in a stock’s price relative to movements in the overall market. The market, such as the S&P 500 Index, has a beta of 1.0. If a stock has a Beta greater (or lower) than 1.0, it suggests that the stock is more (or less) volatile than the broader market.
0
52-week Range info-icon
This shows the range of the stock’s price between the 52-week high (the highest price of the stock for the past 52 weeks) and the 52-week low (the lowest price of the stock for the past 52 weeks).
$5.01 L
$16.44 H
$5.07

About Liminatus Pharma, Inc. Class A Common Stock, Common Stock

Liminatus Pharma, Inc. operates as a clinical-stage immuno-oncology company that develops novel cancer therapies. The company is based in LA Palma, California. more

Returns

Data is not properly formatted.

Financials

Dec '22Dec '23Dec '24
Total Revenue---[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}]
Cost of Revenue---[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}]
Gross Profit---[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}]
Gross Margin---[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}]
Operating Expenses2.71M4.82M-[{"date":"2022-12-31","value":56.21,"profit":true},{"date":"2023-12-31","value":100,"profit":true},{"date":"2024-12-31","value":"-","profit":true}]
Operating Income(2.71M)(4.82M)(405.00)[{"date":"2022-12-31","value":-270900000,"profit":false},{"date":"2023-12-31","value":-481900000,"profit":false},{"date":"2024-12-31","value":-40500,"profit":false}]
Total Non-Operating Income/Expense---[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}]
Pre-Tax Income(2.93M)(4.98M)(405.00)[{"date":"2022-12-31","value":-292800000,"profit":false},{"date":"2023-12-31","value":-498400000,"profit":false},{"date":"2024-12-31","value":-40500,"profit":false}]
Income Taxes---[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}]
Income After Taxes---[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}]
Income From Continuous Operations(2.93M)(4.98M)-[{"date":"2022-12-31","value":-292800000,"profit":false},{"date":"2023-12-31","value":-498400000,"profit":false},{"date":"2024-12-31","value":"-","profit":true}]
Income From Discontinued Operations---[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}]
Net Income(2.93M)(4.98M)(405.00)[{"date":"2022-12-31","value":-292800000,"profit":false},{"date":"2023-12-31","value":-498400000,"profit":false},{"date":"2024-12-31","value":-40500,"profit":false}]
EPS (Diluted)0.30(0.16)(0.40)[{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":-52.85,"profit":false},{"date":"2024-12-31","value":-136.68,"profit":false}]

Ratios

Asset Efficiency

These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.

LIMN
ROA (LTM) 0.00%
ROE (LTM) 0.00%

Valuation

These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.

LIMN
Trailing PE NM
Forward PE NM
P/S (TTM) 0.00
P/B 0.00
EV/R 0.00
EV/Ebitda NM

FAQs

What is Liminatus Pharma, Inc. Class A Common Stock share price today?

Liminatus Pharma, Inc. Class A Common Stock (LIMN) share price today is $5.07

Can Indians buy Liminatus Pharma, Inc. Class A Common Stock shares?

Yes, Indians can buy shares of Liminatus Pharma, Inc. Class A Common Stock (LIMN) on Vested. To buy Liminatus Pharma, Inc. Class A Common Stock from India, you can open a US Brokerage account on Vested today by clicking on Sign Up or Invest in LIMN stock at the top of this page. The account opening process is completely digital and secure, and takes a few minutes to complete.

Can Fractional shares of Liminatus Pharma, Inc. Class A Common Stock be purchased?

Yes, you can purchase fractional shares of Liminatus Pharma, Inc. Class A Common Stock (LIMN) via the Vested app. You can start investing in Liminatus Pharma, Inc. Class A Common Stock (LIMN) with a minimum investment of $1.

How to invest in Liminatus Pharma, Inc. Class A Common Stock shares from India?

You can invest in shares of Liminatus Pharma, Inc. Class A Common Stock (LIMN) via Vested in three simple steps:

  • Click on Sign Up or Invest in LIMN stock at the top of this page
  • Breeze through our fully digital and secure KYC process and open your US Brokerage account in a few minutes
  • Transfer USD funds to your US Brokerage account and start investing in Liminatus Pharma, Inc. Class A Common Stock shares
What is Liminatus Pharma, Inc. Class A Common Stock 52-week high and low stock price?

The 52-week high price of Liminatus Pharma, Inc. Class A Common Stock (LIMN) is $16.44. The 52-week low price of Liminatus Pharma, Inc. Class A Common Stock (LIMN) is $5.01.

What is Liminatus Pharma, Inc. Class A Common Stock price-to-book (P/B) ratio?

The price-to-book (P/B) ratio of Liminatus Pharma, Inc. Class A Common Stock (LIMN) is 0.00

What is the Market Cap of Liminatus Pharma, Inc. Class A Common Stock?

The market capitalization of Liminatus Pharma, Inc. Class A Common Stock (LIMN) is $135.44M

What is Liminatus Pharma, Inc. Class A Common Stock’s stock symbol?

The stock symbol (or ticker) of Liminatus Pharma, Inc. Class A Common Stock is LIMN

Signup to access all features and start your US investing journey!

  • Open your account in minutes
  • Take your portfolio global, starting at just $1
Get started

Add ticker to compare

Scroll to Top